Interestingly, AML1/ETO is necessary, but not sufficient for transformation or leukemia development, and a fraction of the AML1/ETO-expressing stem cells undergo additional oncogenic event(s) that ultimately leads to transformation into AML[44,45]. This evidence concerns the gene RUNX1 and leukemia.